[1] |
Zanardo L, Stolz W, Schmitz G, et al. Progressive hyperpigmentation and generalized lentiginosis without associated systemic symptoms: a rare hereditary pigmentation disorder in south⁃east Germany[J]. Acta Derm Venereol, 2004,84(1):57⁃60. doi: 10.1080/00015550310005780.
|
[2] |
Cardinali G, Kovacs D, Giglio MD, et al. A kindred with familial progressive hyperpigmentation⁃like disorder: implication of fibroblast⁃derived growth factors in pigmentation[J]. Eur J Dermatol, 2009,19(5):469⁃473. doi: 10.1684/ejd.2009.0724.
|
[3] |
Amyere M, Vogt T, Hoo J, et al. KITLG mutations cause familial progressive hyper⁃ and hypopigmentation[J]. J Invest Dermatol, 2011,131(6):1234⁃1239. doi: 10.1038/jid.2011.29.
|
[4] |
Wang ZQ, Si L, Tang Q, et al. Gain⁃of⁃function mutation of KIT ligand on melanin synthesis causes familial progressive hyperpigmentation[J]. Am J Hum Genet, 2009,84(5):672⁃677. doi: 10.1016/j.ajhg.2009.03.019.
|
[5] |
Piqueres⁃Zubiaurre T, Martínez de Lagrán Z, González⁃Pérez R, et al. Familial progressive hyperpigmentation, cutaneous mastocytosis, and gastrointestinal stromal tumor as clinical manifestations of mutations in the c⁃KIT receptor gene[J]. Pediatr Dermatol, 2017,34(1):84⁃89. doi: 10.1111/pde.13040.
|
[6] |
Klein T, Bischoff R. Active metalloproteases of the a disintegrin and metalloprotease (ADAM) family: biological function and structure[J]. J Proteome Res, 2011,10(1):17⁃33. doi: 10.1021/pr100556z.
|
[7] |
Kono M, Sugiura K, Suganuma M, et al. Whole⁃exome sequencing identifies ADAM10 mutations as a cause of reticulate acropigmentation of Kitamura, a clinical entity distinct from Dowling⁃Degos disease[J]. Hum Mol Genet, 2013,22(17):3524⁃3533. doi: 10.1093/hmg/ddt207.
|
[8] |
Okamura K, Abe Y, Araki Y, et al. Behavior of melanocytes and keratinocytes in reticulate acropigmentation of Kitamura[J]. Pigment Cell Melanoma Res, 2016,29(2):243⁃246. doi: 10.1111/pcmr.12453.
|
[9] |
Kono M, Suganuma M, Takama H, et al. Dowling⁃Degos disease with mutations in POFUT1 is clinicopathologically distinct from reticulate acropigmentation of Kitamura[J]. Br J Dermatol, 2015,173(2):584⁃586. doi: 10.1111/bjd.13702.
|
[10] |
Ralser DJ, Lestringant GG, Du⁃Thanh A, et al. Functional implications of novel ADAM10 mutations in reticulate acropigmentation of Kitamura[J]. Br J Dermatol, 2017,177(6):e340⁃e343. doi: 10.1111/bjd.16024.
|
[11] |
Tsutsumi M, Kono M, Akiyama M, et al. Reticulate acropigmentation of Kitamura with a novel ADAM10 mutation: a case report[J]. J Dermatol, 2016,43(8):963⁃965. doi: 10.1111/1346⁃8138.13308.
|
[12] |
Pan Y, Zhong W, Wang H, et al. Reticulate acropigmentation of Kitamura with a novel mutation in ADAM10[J]. Clin Exp Dermatol, 2019,44(6):700⁃703. doi: 10.1111/ced.13832.
|